Evidence map›Paper›PMID 34680293›Full record

ArticleCancers2021

Brain and Breast Cancer Cells with PTEN Loss of Function Reveal Enhanced Durotaxis and RHOB Dependent Amoeboid Migration Utilizing 3D Scaffolds and Aligned Microfiber Tracts.

Annalena Wieland, Pamela L Strissel, Hannah Schorle, Ezgi Bakirci, Dieter Janzen, Matthias W Beckmann, Markus Eckstein, Paul D Dalton, Reiner Strick

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The effects of the tumor suppressor geneTranslational cancer research · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Annalena WielandLaboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Pamela L StrisselLaboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Hannah SchorleLaboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Ezgi BakirciDepartment of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute, University Hospital Wuerzburg, Pleicherwall 2, 97070 Wuerzburg, Germany.ORCID 0000-0002-4938-1540
Dieter JanzenInstitute for Clinical Neurobiology, University Hospital Wuerzburg, Versbacherstrasse 5, 97078 Wuerzburg, Germany.ORCID 0000-0001-7258-9043
Matthias W BeckmannLaboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Markus EcksteinInstitute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.
Paul D DaltonDepartment of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute, University Hospital Wuerzburg, Pleicherwall 2, 97070 Wuerzburg, Germany.
Reiner StrickLaboratory for Molecular Medicine, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuernberg, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.ORCID 0000-0002-8141-7099
Universitätsklinikum Erlangen · DEBavarian Polymer Institute · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Würzburg · DEUniversity of Maryland, Baltimore · USUniversity of Oregon · US

Funding

Deutsche Forschungsgemeinschaft Project number 326998133 - TRR 225 (subproject B01)
6 · The paper itself

Abstract

backgroundGlioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with

methods3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology.

resultsIn contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes.

conclusionsThis study demonstrates a significant role of the

Indexed as

3D microfiber3D tumor modelamoeboid cell migrationbrain cancerbreast cancerdurotaxisPTENRHOROCKtopotaxis

Identifiers

PMID34680293
PMCPMC8533830
OpenAlexW3207434784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.